Solitary pulmonary nodule: benign versus malignant
Differentiation with CT and PET-CT
Ann Leung and Robin Smithuis
Department of Radiology, Stanford University Medical Center, Stanford, California and the Department of Radiology, Rijnland Hospital, Leiderdorp, the Netherlands
A solitary pulmonary nodule is defined as a discrete, well-marginated,
rounded opacity less than or equal to 3 cm in diameter that is completely
surrounded by lung parenchyma, does not touch the hilum or mediastinum, and is
not associated with adenopathy, atelectasis, or pleural effusion.
Lesions
larger than 3 cm are considered masses and are treated as malignancies until
proven otherwise.
The differential diagnosis of a solitary pulmonary nodule is broad and
management depends on whether the lesion is benign or malignant.
In this
overview we will discuss some of the new features that can help to differentiate
between benign and malignant nodules based upon CT and PET-CT
findings.
CT: benign versus malignant
Calcification
Diffuse, central, laminated or popcorn calcifications are benign patterns of
calcification.
These types of calcification are seen in granulomatous disease
and hamartomas.
All other patterns of calcification should not be regarded as
a sign of benignity.
The exception to the rule above is when patients are known to have a primary
tumor.
For instance the diffuse calcification pattern can be seen in patients
with osteosarcoma or chondrosarcoma.
Similarly the central and popcorn
pattern can be seen in patients with GI-tumors and patients who previously had
chemotherapy.
Size
A solitary pulmonary nodule (SPN) is defined as a single intraparenchymal
lesion less than 3 cm in size and not associated with atelectasis or
lymphadenopathy.
A lesion greater than 3 cm in diameter is called a mass.
This distinction is made, because lesions greater than 3 cm are usually
malignant, while smaller lesions can be either benign or malignant.
Swensen et al studied the relationship between the size of a SPN and the
chance of malignancy in a cohort at high risk for lung cancer (1).
Their
findings are listed in the table on the left.
They concluded that benign
nodule detection rate is high, especially if lesions are small.
Of the over
2000 nodules that were less than 4 mm in size, none was malignant.
Growth
Comparison with prior imaging studies is often the most useful procedure to determine the importance of the finding of a SPN, since stability over 2 years is highly associated with benignity.
Shape
Japanese screening studies showed that a polygonal shape and a
three-dimensional ratio > 1.78 was a sign of benignity (2,3).
A polygonal
shape means that the lesion has multiple facets (multi-sided).
A peripheral
subpleural location was also a sign of benignity in this study.
The three-dimensional ratio is measured by obtaining the maximal transverse
dimension and dividing it by the maximal vertical dimension.
A large
three-dimensional ratio indicates that the lesion is relatively flat, which is a
benign sign.
Margin
- Corona radiata sign - highly associated with malignancy (figure)
- Lobulated or scalloped margins - intermediate probability
- Smooth margins - more likely benign unless metastatic in origin
Air Bronchogram sign
Recent studies have showed that an air bronchogram is more commonly seen in
malignant pulmonary nodules.
It is most commonly seen in BAC (bronchoalveolar
cell carcinoma) and adenocarcinoma.
The case on the left shows an airbronchogram seen as a linear lucency (broad arrow) and as a more cystic lucency (small arrow) due to the fact that the bronchus is seen en face.
On the left two solitary pulmonary nodules.
Based upon the morphology,
which lesion has the most malignant features?
The lesion on the far left has a spicuated margin and has lucencies within
it.
The lesion next to it is lobulated in contour and has some spicules
radiating to the pleura.
It is however homogeneous in attenuation.
Based
on these findings we should be most concerned that the lesion on the far left is
malignant.
It proved to be an adenocarninoma, while the other one was a
fungal infection.
The lucencies and frank air bronchograms should not mislead
you in thinking that it probably is infection.
Solid and Ground-glass components
Another result from screening studies is that nodules containing a
ground-glass component are more likely to be malignant (5).
- Partly solid lesions with ground-glass components had a malignancy rate of 63%.
- Nonsolid - only ground-glass lesions had a malignancy rate of 18%.
- Only solid lesions had a malignancy rate of only 7%.
On the far left a lesion that only has a ground-glass appearance and next to
it a lesion that has both ground-glass and solid components.
The likelihood
of malignancy is 1:5 for the lesion on the far left and 2:3 for the lesion with
both ground-glass and solid components.
Contrast enhancement
Contrast enhancement less than 15 HU has a very high predictive value for
benignity (99%).
After a baseline scan, 4 consecutive scans at 1 minute
interval are performed.
This applies only for nodules with the following
selection criteria:
- Nodule > 5mm
- Relatively spherical
- Homogeneous, no necrosis, fat or calcification
- No motion or beam hardening artifacts
PET-CT: benign versus malignant
PET-CT plays an increasingly important role in the evaluation of solitary nodules.
When you perform PET-CT, you have to realize the following:
- PET has a very high sensitivity 95%, but a lesser specificity of only 81%
- PET is false positive in granulomatous disease
- PET is usually false negative in size
With these specificity numbers, there will be false positives in about 20%,
depending on the background prevalence of granulomatous disease.
On the
left a patient with an adenocarcinoma, that was not hypermetabolic on the PET,
so it is a false negative PET.
Conclusion
In the differentiation of benign versus malignant solitary pulmonary nodules
nowadays new imaging features have to be added.
We especially have to look
for the presence of areas of ground-glass opacity, air bronchograms or cavities
and the three-dimensional ratios of a lesion.
With the increasingly important role of PET-CT, we have to be aware of the accuracy of PET-CT and we should have an idea about the prevalence of infectious and non-infectious granulomatous disease in the area that we practice.